Sfoglia per ???browse.type.metadata.typeResearch??? AREA06 - SCIENZE MEDICHE
Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors
1999 Pession, A; Prete, A; Locatelli, Franco; Bella, S; Melchionda, F; Garaventa, A; Burnelli, R; Paolucci, G
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer
2015 Mattiucci, Gian Carlo; Autorino, Rosa; Tringali, Andrea; Perri, Vincenzo; Balducci, Mario; Deodato, Francesco; Gambacorta, Maria Antonietta; Mantini, Giovanna; Tagliaferri, Luca; Mutignani, Massimiliano; Morganti, Alessio Giuseppe
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer
2015 Mattiucci, Gian Carlo; Autorino, R; Tringali, Andrea; Perri, Vincenzo; Balducci, Mario; Deodato, Francesco; Gambacorta, Maria Antonietta; Mantini, Giovanna; Tagliaferri, L; Mutignani, M; Morganti, Ag
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer
2015 Mattiucci, Gian Carlo; Autorino, R; Tringali, Andrea; Perri, Vincenzo; Balducci, Mario; Deodato, Francesco; Gambacorta, Maria Antonietta; Mantini, Giovanna; Tagliaferri, L; Mutignani, M; Morganti, Ag
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors
2013 Ruggiero, Antonio; Rizzo, Daniela; Attina', Giorgio; Lazzareschi, Ilaria; Maurizi, Palma; Ridola, Vita; Mastrangelo, Stefano; Migliorati, R; Bertolini, P; Colosimo, Cesare; Riccardi, Riccardo
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma
2010 Ruggiero, Antonio; Rizzo, Daniela; Attinà, Giorgio; Lazzareschi, Ilaria; Maurizi, Palma; Mastrangelo, Stefano; Migliorati, Roberta; Bertolini, P; Pastore, M; Colosimo, Cesare; Riccardi, Riccardo
Phase I trial of weekly gemcitabin and concurrent radiotherapy in patients with inoperable non small cell lung cancer.
2002 Granone, Pierluigi; Margaritora, Stefano; Cesario, Alfredo; Trodella, Lucio; Valente, Salvatore; Turriziani, Adriana; Macis, Giuseppe; Corbo, Giuseppe Maria; Cellini, Numa; R. M., D'Angelillo; G., Gualano; S., Ramella; D., Galetta
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients.
2009 Morganti, Alessio Giuseppe; Cilla, Savino; Valentini, Vincenzo; Digesù, Cinzia; Macchia, Gabriella; Deodato, Francesco; Ferrandina, Gabriella; Cece, Maria Grazia; Cirocco, Massimo; Garganese, Giorgia; Di Lullo, Liberato; Traficante, Divina; Scarabeo, Francesca; Panunzi, Simona; De Gaetano, Andrea; Sallustio, Giuseppina; Cellini, Numa; Sofo, Luigi; Piermattei, Angelo; Scambia, Giovanni
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients.
2009 Morganti, Alessio Giuseppe; Cilla, Savino; Valentini, Vincenzo; Di Gesù, Cinzia; Macchia, Gabriella; Deodato, Francesco; Ferrandina, Maria Gabriella; Cece, Mg; Traficante, Daniela; Sallustio, Giuseppina; Cellini, Numa; Sofo, Luigi; Piermattei, Angelo; Scambia, Giovanni
Phase I-II study of short-course accelerated radiotherapy (SHARON) for palliation in head and neck cancer
2018 Farina, E.; Capuccini, J.; Macchia, G.; Caravatta, L.; Nguyen, N. P.; Cammelli, S.; Farioli, A.; Rambaldi, G. Z.; Cilla, S.; Wondemagegnhu, T.; Uddin, A. F. M. K.; Sumon, M. A.; Genovesi, D.; Buwenge, M.; Cellini, Francesco; Valentini, Vincenzo; Deodato, Francesco; Morganti, A. G.
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma
2000 Valentini, Vincenzo; Cellini, Numa; Scambia, Giovanni; Mancuso, Salvatore; Manfredi, Riccardo; Smaniotto, Daniela; Benedetti Panici, P; Favale, B; Greggi, S; Margariti, Pa; Tortoreto, F.; Morganti, Ag
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆
2021 Gaspar, N.; Campbell-Hewson, Q.; Gallego Melcon, S.; Locatelli, Franco; Venkatramani, R.; Hecker-Nolting, S.; Gambart, M.; Bautista, F.; Thebaud, E.; Aerts, I.; Morland, B.; Rossig, C.; Canete Nieto, A.; Longhi, A.; Lervat, C.; Entz-Werle, N.; Strauss, S. J.; Marec-Berard, P.; Okpara, C. E.; He, C.; Dutta, L.; Casanova, M.
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
2001 Binks, M; Passweg, J R; Furst, D; Mcsweeney, P; Sullivan, K; Besenthal, C; Finke, J; Peter, H H; van Laar, J; Breedveld, F C; Fibbe, W E; Farge, D; Gluckman, E; Locatelli, Franco; Martini, A; van den Hoogen, F; van de Putte, L; Schattenberg, A V; Arnold, R; Bacon, P A; Emery, P; Espigado, I; Hertenstein, B; Hiepe, F; Kashyap, A; Kötter, I; Marmont, A; Martinez, A; Pascual, M J; Gratwohl, A; Prentice, H G; Black, C; Tyndall, A
Phase I/Phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
2016 Von Stackelberg, A.; Locatelli, Franco; Zugmaier, G.; Handgretinger, R.; Trippett, T. M.; Rizzari, C.; Bader, P.; O'Brien, M. M.; Brethon, B.; Bhojwani, D.; Schlegel, P. G.; Borkhardt, A.; Rheingold, S. R.; Cooper, T. M.; Zwaan, C. M.; Barnette, P.; Messina, C.; Michel, G.; Dubois, S. G.; Hu, K.; Zhu, M.; Whitlock, J. A.; Gore, L.
Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
2020 Amoroso, L.; Castel, V.; Bisogno, G.; Casanova, M.; Marquez-Vega, C.; Chisholm, J. C.; Doz, F.; Moreno, L.; Ruggiero, Antonio; Gerber, N. U.; Fagioli, F.; Hingorani, P.; Melcon, S. G.; Slepetis, R.; Chen, N.; le Bruchec, Y.; Simcock, M.; Vassal, G.
Phase II study of a protracted irinotecan schedule in children wiht refractory or recurrent soft tissue sarcoma
2006 Bisogno, Gianni; Riccardi, Riccardo; Ruggiero, Antonio; Arcamone, G; Prete, Arcangelo; Surico, G.; Provenzi, M.; Bertolini, P.; Paolucci, Paolo; Carli, Modesto
Phase II study of a protracted irinotecan schedule in children with refractory of recurrent soft tissue sarcoma.
2005 Bisogno, Gianni; Riccardi, Riccardo; Ruggiero, Antonio; Arcamone, G; Del Prete, Arcangelo; Surico, G; Provenzi, M; Bertolini, P; Paolucci, Paolo; Carli, Modesto
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
2021 Zhu, A.; Yuan, P.; Hu, N.; Li, M.; Wang, W.; Wang, X.; Yue, J.; Wang, J.; Luo, Y.; Ma, F.; Zhang, P.; Li, Qiu; Xu, B.; Cao, S.; Lippi, G.; Naito, Y.; Osman, M. A.; Marta, G. N.; Franceschini, Gianluca; Orlandi, Armando
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.
2011 Geoerger, B; Chisholm, J; Le Deley, Mc; Gentet, Jc; Zwaan, Cm; Dias, N; Jaspan, T; Hugh, K; Couanet, D; Hain, S; Devos, A; Riccardi, Riccardo; Cesare, C; Boos, J; Frappaz, D; Leblond, P; Aerts, I; Vassal, G.
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
2012 Lorusso, Domenico; Scambia, Giovanni; Amadio, Gabriele; Di Legge, Alessia; Pietragalla, Antonella; De Vincenzo, Rosa Pasqualina; Masciullo, Valeria; Di Stefano, Maurizio; Mangili, G; Citterio, G; Mantori, M; Lambiase, A; Bordignon, C.
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-1999 | Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors | Pession, A; Prete, A; Locatelli, Franco; Bella, S; Melchionda, F; Garaventa, A; Burnelli, R; Paolucci, G | |
| 1-gen-2015 | A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer | Mattiucci, Gian Carlo; Autorino, Rosa; Tringali, Andrea; Perri, Vincenzo; Balducci, Mario; Deodato, Francesco; Gambacorta, Maria Antonietta; Mantini, Giovanna; Tagliaferri, Luca; Mutignani, Massimiliano; Morganti, Alessio Giuseppe | |
| 1-gen-2015 | A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer | Mattiucci, Gian Carlo; Autorino, R; Tringali, Andrea; Perri, Vincenzo; Balducci, Mario; Deodato, Francesco; Gambacorta, Maria Antonietta; Mantini, Giovanna; Tagliaferri, L; Mutignani, M; Morganti, Ag | |
| 1-gen-2015 | A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer | Mattiucci, Gian Carlo; Autorino, R; Tringali, Andrea; Perri, Vincenzo; Balducci, Mario; Deodato, Francesco; Gambacorta, Maria Antonietta; Mantini, Giovanna; Tagliaferri, L; Mutignani, M; Morganti, Ag | |
| 1-gen-2013 | Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors | Ruggiero, Antonio; Rizzo, Daniela; Attina', Giorgio; Lazzareschi, Ilaria; Maurizi, Palma; Ridola, Vita; Mastrangelo, Stefano; Migliorati, R; Bertolini, P; Colosimo, Cesare; Riccardi, Riccardo | |
| 1-gen-2010 | Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma | Ruggiero, Antonio; Rizzo, Daniela; Attinà, Giorgio; Lazzareschi, Ilaria; Maurizi, Palma; Mastrangelo, Stefano; Migliorati, Roberta; Bertolini, P; Pastore, M; Colosimo, Cesare; Riccardi, Riccardo | |
| 1-gen-2002 | Phase I trial of weekly gemcitabin and concurrent radiotherapy in patients with inoperable non small cell lung cancer. | Granone, Pierluigi; Margaritora, Stefano; Cesario, Alfredo; Trodella, Lucio; Valente, Salvatore; Turriziani, Adriana; Macis, Giuseppe; Corbo, Giuseppe Maria; Cellini, Numa; R. M., D'Angelillo; G., Gualano; S., Ramella; D., Galetta | |
| 1-gen-2009 | Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. | Morganti, Alessio Giuseppe; Cilla, Savino; Valentini, Vincenzo; Digesù, Cinzia; Macchia, Gabriella; Deodato, Francesco; Ferrandina, Gabriella; Cece, Maria Grazia; Cirocco, Massimo; Garganese, Giorgia; Di Lullo, Liberato; Traficante, Divina; Scarabeo, Francesca; Panunzi, Simona; De Gaetano, Andrea; Sallustio, Giuseppina; Cellini, Numa; Sofo, Luigi; Piermattei, Angelo; Scambia, Giovanni | |
| 1-gen-2009 | Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. | Morganti, Alessio Giuseppe; Cilla, Savino; Valentini, Vincenzo; Di Gesù, Cinzia; Macchia, Gabriella; Deodato, Francesco; Ferrandina, Maria Gabriella; Cece, Mg; Traficante, Daniela; Sallustio, Giuseppina; Cellini, Numa; Sofo, Luigi; Piermattei, Angelo; Scambia, Giovanni | |
| 1-gen-2018 | Phase I-II study of short-course accelerated radiotherapy (SHARON) for palliation in head and neck cancer | Farina, E.; Capuccini, J.; Macchia, G.; Caravatta, L.; Nguyen, N. P.; Cammelli, S.; Farioli, A.; Rambaldi, G. Z.; Cilla, S.; Wondemagegnhu, T.; Uddin, A. F. M. K.; Sumon, M. A.; Genovesi, D.; Buwenge, M.; Cellini, Francesco; Valentini, Vincenzo; Deodato, Francesco; Morganti, A. G. | |
| 1-gen-2000 | Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma | Valentini, Vincenzo; Cellini, Numa; Scambia, Giovanni; Mancuso, Salvatore; Manfredi, Riccardo; Smaniotto, Daniela; Benedetti Panici, P; Favale, B; Greggi, S; Margariti, Pa; Tortoreto, F.; Morganti, Ag | |
| 1-gen-2021 | Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆ | Gaspar, N.; Campbell-Hewson, Q.; Gallego Melcon, S.; Locatelli, Franco; Venkatramani, R.; Hecker-Nolting, S.; Gambart, M.; Bautista, F.; Thebaud, E.; Aerts, I.; Morland, B.; Rossig, C.; Canete Nieto, A.; Longhi, A.; Lervat, C.; Entz-Werle, N.; Strauss, S. J.; Marec-Berard, P.; Okpara, C. E.; He, C.; Dutta, L.; Casanova, M. | |
| 1-gen-2001 | Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease | Binks, M; Passweg, J R; Furst, D; Mcsweeney, P; Sullivan, K; Besenthal, C; Finke, J; Peter, H H; van Laar, J; Breedveld, F C; Fibbe, W E; Farge, D; Gluckman, E; Locatelli, Franco; Martini, A; van den Hoogen, F; van de Putte, L; Schattenberg, A V; Arnold, R; Bacon, P A; Emery, P; Espigado, I; Hertenstein, B; Hiepe, F; Kashyap, A; Kötter, I; Marmont, A; Martinez, A; Pascual, M J; Gratwohl, A; Prentice, H G; Black, C; Tyndall, A | |
| 1-gen-2016 | Phase I/Phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia | Von Stackelberg, A.; Locatelli, Franco; Zugmaier, G.; Handgretinger, R.; Trippett, T. M.; Rizzari, C.; Bader, P.; O'Brien, M. M.; Brethon, B.; Bhojwani, D.; Schlegel, P. G.; Borkhardt, A.; Rheingold, S. R.; Cooper, T. M.; Zwaan, C. M.; Barnette, P.; Messina, C.; Michel, G.; Dubois, S. G.; Hu, K.; Zhu, M.; Whitlock, J. A.; Gore, L. | |
| 1-gen-2020 | Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network | Amoroso, L.; Castel, V.; Bisogno, G.; Casanova, M.; Marquez-Vega, C.; Chisholm, J. C.; Doz, F.; Moreno, L.; Ruggiero, Antonio; Gerber, N. U.; Fagioli, F.; Hingorani, P.; Melcon, S. G.; Slepetis, R.; Chen, N.; le Bruchec, Y.; Simcock, M.; Vassal, G. | |
| 1-gen-2006 | Phase II study of a protracted irinotecan schedule in children wiht refractory or recurrent soft tissue sarcoma | Bisogno, Gianni; Riccardi, Riccardo; Ruggiero, Antonio; Arcamone, G; Prete, Arcangelo; Surico, G.; Provenzi, M.; Bertolini, P.; Paolucci, Paolo; Carli, Modesto | |
| 1-gen-2005 | Phase II study of a protracted irinotecan schedule in children with refractory of recurrent soft tissue sarcoma. | Bisogno, Gianni; Riccardi, Riccardo; Ruggiero, Antonio; Arcamone, G; Del Prete, Arcangelo; Surico, G; Provenzi, M; Bertolini, P; Paolucci, Paolo; Carli, Modesto | |
| 1-gen-2021 | Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA | Zhu, A.; Yuan, P.; Hu, N.; Li, M.; Wang, W.; Wang, X.; Yue, J.; Wang, J.; Luo, Y.; Ma, F.; Zhang, P.; Li, Qiu; Xu, B.; Cao, S.; Lippi, G.; Naito, Y.; Osman, M. A.; Marta, G. N.; Franceschini, Gianluca; Orlandi, Armando | |
| 1-gen-2011 | Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. | Geoerger, B; Chisholm, J; Le Deley, Mc; Gentet, Jc; Zwaan, Cm; Dias, N; Jaspan, T; Hugh, K; Couanet, D; Hain, S; Devos, A; Riccardi, Riccardo; Cesare, C; Boos, J; Frappaz, D; Leblond, P; Aerts, I; Vassal, G. | |
| 1-gen-2012 | Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients | Lorusso, Domenico; Scambia, Giovanni; Amadio, Gabriele; Di Legge, Alessia; Pietragalla, Antonella; De Vincenzo, Rosa Pasqualina; Masciullo, Valeria; Di Stefano, Maurizio; Mangili, G; Citterio, G; Mantori, M; Lambiase, A; Bordignon, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile